Wooram Park Selected Research

Magnesium Hydroxide (Brucite)

1/2021	PLGA Microspheres Containing Hydrophobically Modified Magnesium Hydroxide Particles for Acid Neutralization-Mediated Anti-Inflammation.
1/2020	Magnesium hydroxide-incorporated PLGA composite attenuates inflammation and promotes BMP2-induced bone formation in spinal fusion.
7/2019	One step bulk modification of poly(L-lactic acid) composites with functional additives to improve mechanical and biological properties for cardiovascular implant applications.
5/2019	Augmented re-endothelialization and anti-inflammation of coronary drug-eluting stent by abluminal coating with magnesium hydroxide.
1/2019	Synergistically enhanced osteoconductivity and anti-inflammation of PLGA/β-TCP/Mg(OH)2 composite for orthopedic applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wooram Park Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 07/2010
8	Inflammation (Inflammations) 01/2021 - 01/2018
5	Hyperplasia 02/2022 - 09/2018
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2014
3	Cytokine Release Syndrome 01/2022 - 12/2020
3	Infections 10/2021 - 12/2020
3	Sepsis (Septicemia) 08/2021 - 12/2020
3	Thrombosis (Thrombus) 01/2020 - 05/2019
2	Pathologic Constriction (Stenosis) 01/2020 - 09/2019
2	Vascular Diseases (Vascular Disease) 01/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 01/2018
2	Liver Neoplasms (Liver Cancer) 08/2018 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 11/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Esophageal Stenosis (Esophageal Stricture) 01/2022
1	Muscular Atrophy (Muscle Atrophy) 12/2021
1	Hypertrophy 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020
1	Bites and Stings (Sting) 10/2020
1	Gastric Outlet Obstruction 01/2020
1	Atherosclerosis 01/2020
1	Pseudarthrosis (Pseudoarthrosis) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 06/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2019

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
10	Photosensitizing Agents (Photosensitizers)IBA 12/2017 - 07/2012
6	PolymersIBA 01/2022 - 03/2013
5	Magnesium Hydroxide (Brucite)FDA Link 01/2021 - 01/2019
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 07/2012
4	Hyaluronic Acid (Hyaluronan)IBA 03/2016 - 07/2010
3	SilverIBA 02/2022 - 09/2018
3	Drug CarriersIBA 01/2022 - 09/2010
3	MetalsIBA 01/2022 - 09/2018
3	Biological ProductsIBA 08/2021 - 11/2011
3	Singlet OxygenIBA 03/2016 - 04/2014
3	MicellesIBA 12/2014 - 01/2014
3	LigandsIBA 08/2014 - 11/2011
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 01/2018
2	Chimeric Antigen ReceptorsIBA 01/2022 - 11/2019
2	HydrogelsIBA 01/2022 - 01/2017
2	CytokinesIBA 01/2022 - 12/2020
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 12/2014
2	Melanins (Melanin)IBA 10/2021 - 12/2020
2	Deoxyribonuclease I (Nickase)IBA 10/2021 - 12/2020
2	Antiviral Agents (Antivirals)IBA 03/2021 - 01/2021
2	AcidsIBA 01/2021 - 07/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2016
2	polydopamineIBA 01/2021 - 03/2016
2	Therapeutic UsesIBA 01/2020 - 10/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2018
2	GoldIBA 06/2019 - 09/2018
2	Cisplatin (Platino)FDA LinkGeneric 11/2016 - 12/2014
2	LipidsIBA 01/2016 - 07/2012
2	phytochlorinIBA 09/2014 - 11/2012
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 11/2013 - 09/2010
1	Cytidine Monophosphate (CMP)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	CPG-oligonucleotideIBA 01/2022
1	VaccinesIBA 01/2022
1	Type A Botulinum Toxins (Botox)FDA Link 12/2021
1	incobotulinumtoxinA FDA Link 12/2021
1	Synaptosomal-Associated Protein 25IBA 12/2021
1	Mitochondrial DNA (mtDNA)IBA 08/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2021
1	MagnesiumIBA 03/2021
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	InterferonsIBA 10/2020
1	SolutionsIBA 10/2020
1	Liposomes (Liposome)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	FibrinIBA 01/2020
1	Ethiodized Oil (Ethiodol)FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	NaGdF4IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	EmulsionsIBA 01/2020

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2011
8	Stents 02/2022 - 09/2018
8	Immunotherapy 01/2022 - 04/2017
8	Photochemotherapy (Photodynamic Therapy) 01/2020 - 07/2012
5	Drug Therapy (Chemotherapy) 01/2022 - 09/2010
4	Drug-Eluting Stents 01/2022 - 01/2018
3	Microspheres (Microsphere) 01/2021 - 04/2017
3	Self Expandable Metallic Stents 06/2020 - 09/2018
3	Lasers (Laser) 01/2016 - 12/2013
2	Nanospheres 10/2021 - 12/2020
1	Radiofrequency Ablation 02/2022
1	Radiotherapy 01/2022
1	Aftercare (After-Treatment) 08/2021
1	Liver Transplantation 01/2021
1	Spinal Fusion (Spondylosyndesis) 01/2020